The FDA told Regeneron in a complete response letter that while it didn't identify any issues with the safety or efficacy of the drug in its approved indications and dosing regimens, the agency didn't ...

The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...

The retinal surgery team, including Professor Nam Dong-heun, Lee Jun-woo, and Professor Kim Ye-won of Gachon University Gil ...

Diabetic retinopathy (DR), a serious eye condition caused by damage to the blood vessels in the retina—the light-sensitive tissue at the back of the eye—is a ma ...